Litvin et al. was the first to publish the initial evidence of a down-regulation of human Panx2 transcripts in Affymetrix chip analysis, particularly in astrocytomas, glioblastoma multiforme (GBM), and oligodendro-gliomas [183]. The gene discussed is PANX2; the disease is glioblastoma.